Rare diseases
Investigational molecules
Locations
Back to Germany1 140 clinical trials in Hamburg, Germany across 19 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
GermanyStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
GermanyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
GermanyStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
GermanyStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
GermanyStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
GermanyStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GermanyStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
GermanyStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
GermanyA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
GermanyStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
GermanyA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Current clinical trials focusing on innovative treatments for metastatic prostate cancer, colorectal cancer, and breast cancer. Studies are evaluating new therapeutic combinations and targeted approaches for improved patient outcomes.
Comprehensive vaccine development programs targeting respiratory syncytial virus, cytomegalovirus, and meningococcal infections. Research focuses on both adult and pediatric populations.
Groundbreaking research in treating acute cerebral ischemic stroke with innovative therapies. Studies are evaluating functional outcomes and safety profiles of new therapeutic agents.
Clinical investigations addressing vaginal atrophy and contraceptive technologies. Research includes novel delivery systems and hormone-based treatments for postmenopausal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
